A generic version of a popular heartburn medication that contains ranitidine — the generic version of Novartis’ Zantac — may be contaminated with a cancer-causing chemical.
A generic version of a popular heartburn medication may be contaminated with a cancer-causing chemical.
The Food and Drug Administration released a statement on Sept. 13 after learning that some ranitidine drugs, “including some products commonly known as the brand-name drug Zantac,” contained low levels of NDMA. “NDMA is classified as a probable human carcinogen based on results from laboratory tests,” noted the agency. NDMA is a “known environmental contaminant” that’s found in water and foods, including cured or grilled meats , dairy products and vegetables, according to the FDA.
So how concerned should you be if you’re taking an over-the-counter or prescription heartburn medication with ranitidine?
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Carcinogen scare sets off global race to contain tainted ZantacDrugmakers and regulators are taking steps to remove supplies of Zantac, a popular heartburn medication, from the market because it may have become tainted with a cancer-causing agent.
Consulte Mais informação »
Drug company halts distribution of popular heartburn drug due to contaminantMedication already in stores will still be available as FDA reviews safety of ingredient linked to increase in cancer risk.
Consulte Mais informação »
New study finds cancer-causing chemicals in tap waterA new Environmental Working Group study says there are contaminants in drinking water that could increase the risk of cancer.
Consulte Mais informação »
Exclusive: London Metal Exchange to delay ban on tainted metal until 2025 - sourcesThe London Metal Exchange (LME) will postpone plans to ban metal tainted by huma...
Consulte Mais informação »
That popular 'Pokémon Sword and Shield' leak called Sirfetch'd back in MayAnother point for the 'Affleck leak.'
Consulte Mais informação »